Literature DB >> 15486794

[Usefulness of anal endosonography in the assessment of fistula-in-ano].

D Bussen1, M Sailer, S Wening, K-H Fuchs, A Thiede.   

Abstract

AIM: The purpose of the present study was to define the diagnostic value of anal endosonography in the diagnostic work-up of fistula-in-ano.
METHODS: A retrospective study was carried out on 191 consecutive patients (m: 121; f: 70; mean age: 44.0 +/- 12.5 years; range: 0.5-77 years) who were diagnosed to suffer from fistula-in-ano by performing anal endosonography in an outpatient setting. All images were obtained with a Combison 310A ultrasound scanner (Kretz GmbH, Zipf, Osterreich) and 5-Mhz and 7.5-MHz transducer. 131 patients underwent surgery. According to the endosonographic findings fistulas were classified as transsphincteric in 44 %, intersphincteric in 22 %, subanodermal in 16 %, anovaginal in 8 %, suprasphincteric in 5 %, extrasphincteric in 1 % and others in 4 %.
RESULTS: In 125 patients (95 %) the preoperative diagnosis was confirmed intraoperatively. This cohort included 12 patients with a complex fistula system. In only 6 patients the preoperative ultrasound finding was misinterpreted.
CONCLUSION: In conclusion this study has shown that anal endosonography is a useful and reliable tool in the preoperative evaluation of uncomplicated and complicated anorectal fistulas.

Entities:  

Mesh:

Year:  2004        PMID: 15486794     DOI: 10.1055/s-2004-820362

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Cryptoglandular anal fistulas.

Authors:  Andreas Ommer; Alexander Herold; Eugen Berg; Alois Fürst; Marco Sailer; Thomas Schiedeck
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

Review 2.  German S3 guidelines: anal abscess and fistula (second revised version).

Authors:  Andreas Ommer; Alexander Herold; Eugen Berg; Alois Fürst; Stefan Post; Reinhard Ruppert; Thomas Schiedeck; Oliver Schwandner; Bernhard Strittmatter
Journal:  Langenbecks Arch Surg       Date:  2017-03-01       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.